Skip to content

Clinical trials

Lymphoma, Large-Cell, Anaplastic trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Not applicable Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20074
20082
20092
20101
20111
20131
20151
20161
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
Wake Forest University Health Sciences3
Case Comprehensive Cancer Center2
City of Hope Medical Center2
Mayo Clinic2
Roswell Park Cancer Institute2
Astex Pharmaceuticals, Inc.1
Eastern Cooperative Oncology Group1
M.D. Anderson Cancer Center1
Ohio State University Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic21
Lymphoma, Large B-Cell, Diffuse18
Burkitt Lymphoma17
Immunoblastic Lymphadenopathy17
Leukemia, Lymphocytic, Chronic, B-Cell17
Lymphoma, Follicular17
Lymphoma, Extranodal NK-T-Cell16
Lymphoma, Mantle-Cell16
Precursor Cell Lymphoblastic Leukemia-Lymphoma16
Lymphoma, B-Cell, Marginal Zone15

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.